Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

被引：0
|
作者：
Shuying Dong
Jian Kong
Fandong Kong
Jinge Kong
Jun Gao
Liang Ji
Bing Pan
Lian Chen
Lemin Zheng
Wenbing Sun
机构：
[1] Capital Medical University,Department of Hepatobiliary Surgery, Beijing Chao
[2] The Institute of Cardiovascular Sciences and Institute of Systems Biomedicine,yang Hospital
[3] Peking University Health Science Center,School of Basic Medical Sciences, and Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education
[4] The Neuroscience Research Institute,Department of Neurobiology, School of Basic Medical Sciences
[5] Peking University,Key Laboratory for Neuroscience, Ministry of Education/National Health and Family Planning Commission
[6] Peking University,The 8th Department of Orthopaedics
[7] Affiliated Mindong Hospital of Fujian Medical University,undefined
来源：
BMC Cancer | / 15卷
关键词：
Hepatocellular carcinoma; Insufficient radiofrequency ablation; Epithelial-mesenchymal transition; Sorafenib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
    Dong, Shuying
    Kong, Jian
    Kong, Fandong
    Kong, Jinge
    Gao, Jun
    Ji, Liang
    Pan, Bing
    Chen, Lian
    Zheng, Lemin
    Sun, Wenbing
    BMC CANCER, 2015, 15
  • [2] Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways
    Shuying Dong
    Jian Kong
    Fandong Kong
    Jinge Kong
    Jun Gao
    Shan Ke
    Shaohong Wang
    Xuemei Ding
    Wenbing Sun
    Lemin Zheng
    Journal of Translational Medicine, 11
  • [3] Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways
    Dong, Shuying
    Kong, Jian
    Kong, Fandong
    Kong, Jinge
    Gao, Jun
    Ke, Shan
    Wang, Shaohong
    Ding, Xuemei
    Sun, Wenbing
    Zheng, Lemin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [4] Expression of epithelial-mesenchymal transition markers in locally recurrent hepatocellular carcinoma after radiofrequency ablation
    Tajima, Hidehiro
    Ohta, Tetsuo
    Shoji, Yasuhiro
    Watanabe, Toshifumi
    Makino, Isamu
    Hayashi, Hironori
    Nakagawara, Hisatoshi
    Onishi, Ichiro
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Kitagawa, Hirohisa
    Fushida, Sachio
    Tani, Takashi
    Fujimura, Takashi
    Kayahara, Masato
    Arai, Kuniaki
    Yamashita, Tatsuya
    Kaneko, Shuichi
    Zen, Yoh
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (02) : 347 - 350
  • [5] Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo
    Xu, Ming
    Xie, Xiao-hua
    Xie, Xiao-yan
    Xu, Zuo-feng
    Liu, Guang-jian
    Zheng, Yan-ling
    Huang, Guang-liang
    Wang, Wei
    Zheng, Shu-guang
    Lu, Ming-de
    ACTA RADIOLOGICA, 2013, 54 (02) : 199 - 204
  • [6] Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation
    Iwahashi, Shuichi
    Shimada, Mitsuo
    Utsunomiya, Tohru
    Imura, Satoru
    Morine, Yuji
    Ikemoto, Tetsuya
    Takasu, Chie
    Saito, Yu
    Yamada, Shinichiro
    CANCER LETTERS, 2016, 375 (01) : 47 - 50
  • [7] Epithelial-mesenchymal transition in hepatocellular carcinoma
    van Zijl, Franziska
    Zulehner, Gudrun
    Petz, Michaela
    Schneller, Doris
    Kornauth, Christoph
    Hau, Mara
    Machat, Georg
    Grubinger, Markus
    Huber, Heidemarie
    Mikulits, Wolfgang
    FUTURE ONCOLOGY, 2009, 5 (08) : 1169 - +
  • [8] Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
    Deng, Yan-Ru
    Liu, Wen-Bin
    Lian, Zhe-Xiong
    Li, Xingsheng
    Hou, Xin
    ONCOTARGET, 2016, 7 (25) : 38292 - 38305
  • [9] Epithelial mesenchymal transition and response to sorafenib treatment in hepatocellular carcinoma cells
    Park, Su Cheol
    Yang, Ki Young
    Kim, Yeon Joo
    Han, Chul Joo
    Kim, Jin
    Kim, You Cheoul
    Choi, Su Jin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 269 - 269
  • [10] An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
    Guo, Yusheng
    Ren, Yanqiao
    Dong, Xiangjun
    Kan, Xuefeng
    Zheng, Chuansheng
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 343 - 355
12345